Clifford Chance has advised Neuraxpharm Group on the deal. Neuraxpharm Group acquired two portfolios of established products from Sanofi which are marketed globally in more than...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised Alcentra on the financing of 3i’s investment in MAIT GmbH. Willkie advised 3i Group on the deal. The MAIT Group, headquartered in Rottweil,...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised KKR and Roompot on the deal. Houthoff advised Platinum Equity and Latham & Watkins LLP advised Platinum Equity’ portfolio company Awaze. KKR and...
You must be a Standard 1 Year member to access this content.
